TW200640502A - Tablets with improved drug substance dispersibility - Google Patents

Tablets with improved drug substance dispersibility

Info

Publication number: TW200640502A
Authority: TW; Taiwan
Prior art keywords: drug substance; tablets; improved drug; carrier; dispersibility
Prior art date: 2005-02-25

Application number

TW095106135A

Other languages

English (en)

Inventor

Nathalie Bernigal

Eric Garcia

Susanne Page

Joseph Tardio

Original Assignee

Hoffmann La Roche

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-02-25

Filing date

2006-02-23

Publication date

2006-12-01

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36406213&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TW200640502(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2006-02-23 Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche

2006-12-01 Publication of TW200640502A publication Critical patent/TW200640502A/zh

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Epidemiology (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Inorganic Chemistry (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

TW095106135A 2005-02-25 2006-02-23 Tablets with improved drug substance dispersibility TW200640502A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP05101458		2005-02-25

Publications (1)

Publication Number	Publication Date
TW200640502A true TW200640502A (en)	2006-12-01

Family

ID=36406213

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
TW095106135A TW200640502A (en)	2005-02-25	2006-02-23	Tablets with improved drug substance dispersibility

Country Status (20)

Country	Link
US (2)	US20060193910A1 (zh)
EP (2)	EP1855655A2 (zh)
JP (1)	JP2008531509A (zh)
KR (1)	KR20070094666A (zh)
CN (1)	CN101128189A (zh)
AR (1)	AR055561A1 (zh)
AU (1)	AU2006218193A1 (zh)
BR (1)	BRPI0606187A2 (zh)
CA (1)	CA2598762A1 (zh)
CR (1)	CR9292A (zh)
IL (1)	IL185011A0 (zh)
MA (1)	MA29268B1 (zh)
MX (1)	MX2007009571A (zh)
NO (1)	NO20074092L (zh)
NZ (1)	NZ560232A (zh)
RU (1)	RU2007129642A (zh)
TW (1)	TW200640502A (zh)
UA (1)	UA90708C2 (zh)
WO (1)	WO2006089674A2 (zh)
ZA (1)	ZA200706495B (zh)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE10026698A1 (de)	2000-05-30	2001-12-06	Basf Ag	Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
GB0123400D0 (en)	2001-09-28	2001-11-21	Novartis Ag	Organic compounds
US8025899B2 (en)	2003-08-28	2011-09-27	Abbott Laboratories	Solid pharmaceutical dosage form
US8377952B2 (en)	2003-08-28	2013-02-19	Abbott Laboratories	Solid pharmaceutical dosage formulation
EP2018157A2 (en) *	2006-04-26	2009-01-28	Astron Research Limited	Controlled release formulation comprising anti-epileptic drugs
EP2207533B1 (en) *	2007-10-10	2021-01-06	Avantor Performance Materials, LLC	Directly compressible high functionality granular microcrystalline cellulose based excipient, manufacturing process and use thereof
US20100055180A1 (en) *	2007-10-10	2010-03-04	Mallinckrodt Baker, Inc.	Directly Compressible Granular Microcrystalline Cellulose Based Excipient, Manufacturing Process and Use Thereof
DE102008047910A1 (de)	2008-09-19	2010-03-25	Molkerei Meggle Wasserburg Gmbh & Co. Kg	Tablettierhilfsstoff auf Laktose- und Cellulosebasis
PE20160746A1 (es) *	2009-01-23	2016-08-01	Hoffmann La Roche	Composicion farmaceutica que comprende aleglitazar
EP2722045B1 (en)	2009-11-18	2016-07-06	Helsinn Healthcare SA	Compositions for treating centrally mediated nausea and vomiting
EP2361090B1 (en)	2009-11-18	2014-05-21	Helsinn Healthcare SA	Compositions for treating centrally mediated nausea and vomiting
CN102641302B (zh) *	2011-02-18	2016-01-20	上海张江中药现代制剂技术工程研究中心	一种提高中药提取物浸膏粉软化点的方法
RU2468789C1 (ru) *	2011-05-04	2012-12-10	Федеральное государственное бюджетное учреждение науки Иркутский институт химии им. А.Е. Фаворского Сибирского отделения Российской академии наук (ИрИХ СО РАН)	Средство для профилактики и лечения атеросклероза
CN104784239B (zh) *	2015-04-28	2017-12-26	新乡医学院第一附属医院	一种快速溶出的珍菊降压片及其制备工艺
KR20170003414A (ko) *	2015-06-30	2017-01-09	(주)아모레퍼시픽	속붕해형 과립환 모발 세정용 조성물
WO2017003137A1 (ko) *	2015-06-30	2017-01-05	(주)아모레퍼시픽	속붕해형 과립환 모발 세정용 조성물
PE20191239A1 (es)	2016-11-16	2019-09-16	Abide Therapeutics Inc	Formas cristalinas de un inhibidor de magl
MY199448A (en) *	2016-11-16	2023-10-29	H Lundbeck As	Pharmaceutical formulations
CN109701441B (zh) *	2018-12-16	2021-04-09	桂林理工大学	一种卵磷脂选择性改性高岭石的制备方法及其应用
TWI728709B (zh) *	2020-02-19	2021-05-21	台灣森本生物科技開發股份有限公司	含有得自於藤黃樹脂的丙酮萃取產物的藥學組成物以及由該組成物所製得的配方
CN111548218A (zh) *	2020-04-27	2020-08-18	上海应用技术大学	一种通用型花肥速释片及其制备方法和应用
CN116602928A (zh) *	2023-06-30	2023-08-18	康普药业股份有限公司	一种甲苯磺酸艾多沙班组合物和制备方法
US12296050B2 (en) *	2023-10-05	2025-05-13	Mirum Pharmaceuticals, Inc.	Pharmaceutical compositions comprising maralixibat and uses thereof
CN119857081B (zh) *	2025-01-16	2025-10-17	江苏亚邦爱普森药业有限公司	一种乌帕替尼缓释片及其制备方法

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
UA37214C2 (uk) *	1991-01-30	2001-05-15	Дзе Веллкам Фаундейшн Лімітед	Таблетки, що диспергуються у воді, та спосіб їх виготовлення
EP1082959A1 (en)	1991-09-20	2001-03-14	Glaxo Group Limited	NK1 Antagonists for the treatment of depression
JP4334616B2 (ja)	1994-09-22	2009-09-30	ナームローゼ・フエンノートチヤツプ・オルガノン	湿式粒状化による投与単位体を製造する方法
US6106865A (en) *	1995-01-09	2000-08-22	Edward Mendell Co., Inc.	Pharmaceutical excipient having improved compressibility
IT1276160B1 (it) *	1995-11-22	1997-10-27	Recordati Chem Pharm	Composizioni farmaceutiche orali a pronto rilascio per sospensioni estemporanee
WO1998024438A1 (en)	1996-12-02	1998-06-11	Merck Sharp & Dohme Limited	Use of nk-1 receptor antagonists for treating major depressive disorders
AU736042B2 (en)	1996-12-02	2001-07-26	Merck Sharp & Dohme Limited	Use of NK-1 receptor antagonists for treating major depressive disorders with anxiety
FR2758459B1 (fr) *	1997-01-17	1999-05-07	Pharma Pass	Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation
JP4367723B2 (ja) *	1997-08-25	2009-11-18	大正製薬株式会社	水難溶性成分を配合した固形剤
GB9825242D0 (en)	1998-11-19	1999-01-13	Cambridge Advanced Tech	Genetically modified plants with altered starch
PE20001302A1 (es) *	1998-11-27	2000-11-30	Hoffmann La Roche	Preparaciones de una combinacion farmaceutica que contiene carvedilol e hidroclorotiazida
ES2226622T3 (es)	1999-02-24	2005-04-01	F. Hoffmann-La Roche Ag	Derivados de 4-fenil piridina y su empleo como antagonistas del receptor nk-1.
JP4068305B2 (ja)	1999-02-24	2008-03-26	エフ．ホフマン−ラロシュアーゲー	３−フェニルピリジン誘導体、およびそのｎｋ−１受容体拮抗薬としての用途
BR0008489A (pt)	1999-02-24	2002-02-05	Hoffmann La Roche	Derivados de fenil- e piridinila
WO2000053772A1 (en)	1999-03-06	2000-09-14	Roche Diagnostics Gmbh	Dna polymerase from pyrobaculum islandicum
TW550258B (en)	1999-05-31	2003-09-01	Hoffmann La Roche	4-phenyl-pyrimidine derivatives
JO2308B1 (en)	1999-05-31	2005-09-12	اف. هوفمان- لاروش أيه جي‏	Derivatives of phenylpyrmidine
FR2795961B1 (fr) *	1999-07-09	2004-05-28	Ethypharm Lab Prod Ethiques	Composition pharmaceutique contenant du fenofibrate micronise, un tensioactif et un derive cellulosique liant et procede de preparation
US7863331B2 (en) *	1999-07-09	2011-01-04	Ethypharm	Pharmaceutical composition containing fenofibrate and method for the preparation thereof
ATE253561T1 (de)	1999-11-29	2003-11-15	Hoffmann La Roche	2-(3,5-bis-trifluoromethyl-phenyl)-n-methyl-n-( - morpholin-4-yl-4-o-tolyl-pyridin-3-yl)- isobutyramid
US6303790B1 (en)	1999-11-29	2001-10-16	Hoffman-La Roche Inc.	Process for the preparation of pyridine derivatives
AUPQ514600A0 (en)	2000-01-18	2000-02-10	James Cook University	Brain injury treatment
US6452001B2 (en)	2000-05-25	2002-09-17	Hoffmann-La Roche Inc.	Diazapane derivatives useful as antagonists of neurokinin 1 receptor and methods for their formation
US6482829B2 (en)	2000-06-08	2002-11-19	Hoffmann-La Roche Inc.	Substituted heterocyclic siprodecane compound active as an antagonist of neurokinin 1 receptor
HU230316B1 (hu)	2000-07-14	2016-01-28	F. Hoffmann-La Roche Ag	N-oxidok, mint 4-fenil-piridin-származékok előgyógyszerei, eljárás és előállításukra és az ezeket tartalmazó gyógyszerkészítmények
TWI287003B (en)	2000-07-24	2007-09-21	Hoffmann La Roche	4-phenyl-pyridine derivatives
TWI259180B (en)	2000-08-08	2006-08-01	Hoffmann La Roche	4-Phenyl-pyridine derivatives
YU39503A (sh)	2000-11-22	2006-05-25	F. Hoffmann-La Roche Ag.	Derivati pirimidina
CN1263446C (zh)	2000-12-14	2006-07-12	弗·哈夫曼-拉罗切有限公司	自乳化脂质基质(selm)
US6642226B2 (en)	2001-02-06	2003-11-04	Hoffman-La Roche Inc.	Substituted phenyl-piperidine methanone compounds
US6531597B2 (en)	2001-02-13	2003-03-11	Hoffmann-La Roche Inc.	Process for preparation of 2-phenyl acetic acid derivatives
MXPA03009720A (es)	2001-04-23	2004-01-29	Hoffmann La Roche	USO DE ANTAGONISTAS DEL RECEPTOR DE NK-1 PARA TRATAMIENTO O PREVENCIoN DE HIPERPLASIA PROSTATICA BENIGNA.
CA2447329C (en)	2001-05-14	2009-07-28	F.Hoffmann-La Roche Ag	1-oxa-3,9-diaza-spiro[5,5]undecan-2-ones derivatives and its use as antagonist of the neurikinin receptor
US20030083345A1 (en)	2001-07-10	2003-05-01	Torsten Hoffmann	Method of treatment and/or prevention of brain, spinal or nerve injury
US6849624B2 (en)	2001-07-31	2005-02-01	Hoffmann-La Roche Inc.	Aromatic and heteroaromatic substituted amides
US6667327B2 (en)	2002-02-04	2003-12-23	Hoffmann-La Roche Inc.	Pyridine amido derivatives
US6660736B2 (en)	2002-03-27	2003-12-09	Hoffmann-La Roche Inc.	Phthalimido derivatives and a process for their preparation
ATE440821T1 (de)	2002-04-26	2009-09-15	Hoffmann La Roche	Isochinolinderivate als mao-b inhibitoren
ATE430726T1 (de)	2002-05-29	2009-05-15	Hoffmann La Roche	N-acylamino-benzyletherderivate als selektive inhibitoren der monoaminoxidase b
US6951884B2 (en)	2002-06-12	2005-10-04	Hoffmann-La Roche Inc.	Fluorobenzamides and uses thereof
KR20030095600A (ko) *	2002-06-12	2003-12-24	환인제약 주식회사	펠로디핀을 포함하는 제어방출형 조성물 및 그 제조방법
US6900354B2 (en)	2002-07-15	2005-05-31	Hoffman-La Roche Inc.	3-phenyl-propionamido, 3-phenyl-acrylamido and 3-phenyl-propynamido derivatives
US6846832B2 (en)	2002-08-07	2005-01-25	Hoffman-La Roche Inc.	2,3-dihydro-isoindol-1-one derivatives
TWI286132B (en)	2002-09-20	2007-09-01	Hoffmann La Roche	4-pyrrolidino-phenyl-benzyl ether derivatives
JP2006056781A (ja) *	2002-11-15	2006-03-02	Bioserentack Co Ltd	界面活性剤を含む固形化製剤
PL377474A1 (pl)	2002-12-13	2006-02-06	F. Hoffmann-La Roche Ag	Pochodne 3H-chinazolin-4-onu
PL378404A1 (pl)	2003-01-31	2006-04-03	F. Hoffmann-La Roche Ag	Nowa odmiana krystaliczna 2-(3,5-bis-trifluorometylofenylo)-N-[6-(1,1-diokso-1<$Elambda>6 -tiomorfolin-4-ylo)-4-(4-fluoro-2-metylofenylo)pirydyn-3-ylo]-N-metyloizobutyroamidu
FR2851918B1 (fr) *	2003-03-06	2006-06-16		Poudre impregnee ameliorant la biodisponibilite et/ou la solubilite et procede de fabrication
US20060068010A1 (en) *	2004-09-30	2006-03-30	Stephen Turner	Method for improving the bioavailability of orally delivered therapeutics

2006
- 2006-02-16 BR BRPI0606187-7A patent/BRPI0606187A2/pt not_active IP Right Cessation
- 2006-02-16 EP EP06706996A patent/EP1855655A2/en not_active Ceased
- 2006-02-16 RU RU2007129642/15A patent/RU2007129642A/ru not_active Application Discontinuation
- 2006-02-16 AU AU2006218193A patent/AU2006218193A1/en not_active Abandoned
- 2006-02-16 CA CA002598762A patent/CA2598762A1/en not_active Abandoned
- 2006-02-16 CN CNA2006800061155A patent/CN101128189A/zh active Pending
- 2006-02-16 MX MX2007009571A patent/MX2007009571A/es not_active Application Discontinuation
- 2006-02-16 JP JP2007556532A patent/JP2008531509A/ja active Pending
- 2006-02-16 KR KR1020077019272A patent/KR20070094666A/ko not_active Ceased
- 2006-02-16 UA UAA200710576A patent/UA90708C2/ru unknown
- 2006-02-16 NZ NZ560232A patent/NZ560232A/en not_active IP Right Cessation
- 2006-02-16 WO PCT/EP2006/001395 patent/WO2006089674A2/en not_active Ceased
- 2006-02-16 EP EP10179258A patent/EP2281556A1/en not_active Withdrawn
- 2006-02-17 US US11/357,303 patent/US20060193910A1/en not_active Abandoned
- 2006-02-23 AR ARP060100652A patent/AR055561A1/es not_active Application Discontinuation
- 2006-02-23 TW TW095106135A patent/TW200640502A/zh unknown
2007
- 2007-08-02 IL IL185011A patent/IL185011A0/en unknown
- 2007-08-03 ZA ZA200706495A patent/ZA200706495B/xx unknown
- 2007-08-07 CR CR9292A patent/CR9292A/es not_active Application Discontinuation
- 2007-08-08 NO NO20074092A patent/NO20074092L/no not_active Application Discontinuation
- 2007-08-24 MA MA30164A patent/MA29268B1/fr unknown
2009
- 2009-08-17 US US12/542,163 patent/US20090304795A1/en not_active Abandoned

Also Published As

Publication number	Publication date
MX2007009571A (es)	2007-09-21
JP2008531509A (ja)	2008-08-14
ZA200706495B (en)	2008-10-29
NZ560232A (en)	2010-11-26
NO20074092L (no)	2007-09-04
IL185011A0 (en)	2007-12-03
CA2598762A1 (en)	2006-08-31
AR055561A1 (es)	2007-08-22
BRPI0606187A2 (pt)	2009-06-09
RU2007129642A (ru)	2009-03-27
CN101128189A (zh)	2008-02-20
WO2006089674A2 (en)	2006-08-31
MA29268B1 (fr)	2008-02-01
EP1855655A2 (en)	2007-11-21
CR9292A (es)	2010-04-21
WO2006089674A3 (en)	2007-02-08
EP2281556A1 (en)	2011-02-09
US20090304795A1 (en)	2009-12-10
US20060193910A1 (en)	2006-08-31
KR20070094666A (ko)	2007-09-20
AU2006218193A1 (en)	2006-08-31
UA90708C2 (ru)	2010-05-25

Publication	Publication Date	Title
TW200640502A (en)	2006-12-01	Tablets with improved drug substance dispersibility
WO2006078593A3 (en)	2006-09-14	Direct compression formulation and process
WO2008063910A3 (en)	2009-06-18	Method of preparing solid dosage forms of multi-phasic pharmaceutical compositions
WO2003035051A3 (en)	2004-03-11	The use of proton sequestering agents in drug formulations
WO2002074247A8 (en)	2003-01-03	Pharmaceutical formulations for sustained release
WO2006011159A3 (en)	2006-07-06	Stabilized pharmaceutical composition containing rabeprazole sodium with improved bioavailability
EA017764B8 (ru)	2013-05-30	Фармацевтическая композиция, способ ее получения и способ лечения вирусных заболеваний с ее использованием
WO2008007151A3 (en)	2008-03-06	Processes for preparing pharmaceutical compositions
UA100866C2 (ru)	2013-02-11	Продукт твердой дисперсии, который содержит соединения на основе n-арилмочевины
WO2009122301A3 (en)	2009-11-26	Rasagiline mesylate particles and process for the preparation thereof
WO2009074286A3 (en)	2009-07-30	Pharmaceutical formulation comprising ezetimibe
EA200900572A1 (ru)	2009-10-30	Мицеллярные наночастицы с химическими субстанциями
WO2010021607A3 (en)	2010-06-03	Pharmaceutical formulation
EP1847260A3 (en)	2009-11-11	Solid dispersion preparation
WO2008049633A8 (en)	2009-04-09	Spray-freeze-drying process for the preparation of pellets comprising percolation drying
WO2003082262A3 (en)	2004-07-29	Compositions of venlafaxine base
WO2008069938A3 (en)	2008-10-09	Method of forming a tablet comprising pre-blend of ibupropen and silicon dioxide
MX2010004291A (es)	2010-08-02	Producto de dispersion solida de farmacos basados en n-aril urea.
CN106139156A (zh)	2016-11-23	一种含有喹啉衍生物或其盐的药物组合物
GEP20125636B (en)	2012-09-10	Slow-release formulation based on glycogen and alginate association
TW200621310A (en)	2006-07-01	A process for preparing formulations of lypophilic active substances by spray freeze drying
WO2007120838A3 (en)	2008-12-04	Rapidly disintegrating solid oral dosage form of liquid dispersions
WO2008030512A3 (en)	2008-04-24	Polystyrene sulfonate polymer tablets, their preparation and use
WO2008041073A8 (en)	2008-06-05	Sustained release pharmaceutical compositions of venlafaxine and process for preparation thereof
WO2007086911A3 (en)	2008-04-17	Stable nanoparticle formulations